Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant.
Sabulski, A; Davies, SM; Paulsen, G; Kumar, A; Grimley, M; Chandra, S.
Journal of Clinical Immunology.
2020;
40:1171-1175.
MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia.
Itskovich, SS; Gurunathan, A; Clark, J; Burwinkel, M; Wunderlich, M; Berger, MR; Kulkarni, A; Chetal, K; Venkatasubramanian, M; Salomonis, N; et al.
Nature Communications.
2020;
11.
MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.
Liu, H; Osterburg, AR; Flury, J; Swank, Z; McGraw, DW; Gupta, N; Wikenheiser-Brokamp, KA; Kumar, A; Tazi, A; Inoue, Y; et al.
JCI insight.
2020;
5.
High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.
Lee, LH; Krupski, C; Clark, J; Wunderlich, M; Lorsbach, RB; Grimley, MS; Burwinkel, M; Nelson, A; Kumar, AR.
Blood Advances.
2020;
4:717-727.
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).
Jordan, MB; Allen, CE; Greenberg, J; Henry, M; Hermiston, ML; Kumar, A; Hines, M; Eckstein, O; Ladisch, S; Nichols, KE; et al.
Pediatric Blood and Cancer.
2019;
66.
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults.
La Rosee, P; Horne, A; Hines, M; Greenwood, TV B; Machowicz, R; Berliner, N; Birndt, S; Gil-Herrera, J; Girschikofsky, M; Jordan, MB; et al.
Blood.
2019;
133:2465-2477.
Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
Gurunathan, A; Boucher, AA; Mark, M; Prus, KM; O'Brien, MM; Breese, EH; Mizukawa, BE; Absalon, MJ; Nelson, AS; Jordan, MB; et al.
Pediatric Blood and Cancer.
2018;
65:e27400-e27400.
Rituximab therapy for patients with Langerhans cell histiocytosis-associated neurologic dysfunction.
Eckstein, O; McAtee, CL; Greenberg, J; Kumar, A; Fein-Levy, C; Smith, T; Tran, B; McClain, KL.
Pediatric Hematology-Oncology (Informa).
2018;
35:427-433.
Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis.
Lucchini, G; Marsh, R; Gilmour, K; Worth, A; Nademi, Z; Rao, A; Booth, C; Amrolia, P; Silva, J; Chiesa, R; et al.
Blood.
2018;
132:2088-2096.
Diagnosis and management of chronic and refractory immune cytopenias in children, adolescents, and young adults.
Rotz, SJ; Ware, RE; Kumar, A.
Pediatric Blood and Cancer.
2018;
65:e27260-e27260.